Physician profile
Nathan Olszewski
NPI 1376905109
$12,287.40
in general payments reported to CMS, 2019-2025
11 companies · $3,271 in 2025
The $3,271 reported for 2025 was more than what a typical Orthopaedic Trauma provider received nationally (typical 2025 total: $1,227).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $473 · 2020: $28.54 · 2021: $1,371 · 2022: $4,683 · 2023: $1,181 · 2024: $1,280 · 2025: $3,271.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,105 · Travel and Lodging: $2,626.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,105.07 |
| Travel and Lodging | $2,626.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $5,313.12 | 2020-2025 | Pro, T2 Alpha, Gamma |
| Summit Surgical Corp. | $2,400.00 | 2022 | |
| Kairos Surgical INC | $1,937.03 | 2021-2025 | |
| Smith+Nephew, INC. | $1,159.45 | 2021-2025 | Evos, Trigen Intertan, Trigen |
| Medical Device Business Services, INC. | $473.30 | 2019 | |
| Zimmer Biomet Holdings, INC. | $364.83 | 2022-2023 | Affixus |
| Nuvasive Specialized Orthopedics, INC. | $181.93 | 2022 | |
| Arthrex, INC. | $180.40 | 2023 | |
| Orthofix Medical, INC. | $161.08 | 2024 | Physio-Stim |
| Aroa Biosurgery Incorporated | $69.17 | 2025 | |
| Depuy Synthes Sales INC. | $47.09 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nathan Olszewski listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.